MGH settles drug diversion case for $2.3 million

Massachusetts General Hospital has agreed to pay the United States $2.3 million to resolve allegations that lax controls enabled MGH employees to divert controlled substances such as oxycodone for personal use. The Justice Department announced the settlement Monday afternoon, calling it the largest of its kind involving allegations of drug diversion at a hospital.
"Under the law, hospitals like MGH have a special responsibility to ensure that controlled substances are used for patient care and are not diverted for non-medical uses," U.S. Attorney Carmen Ortiz said in a statement. "Diversion of these drugs feeds addiction, contributes to potential illegal drug sales, and fuels the opioid epidemic that has had a devastating effect on the Commonwealth."